Levocetirizine Teva (Levocetirizine Dihydrochloride)

Levocetirizine works by selectively antagonizing peripheral histamine H1 receptors. By blocking these receptors, it prevents histamine‑mediated vascular leakage, nerve stimulation, and inflammatory responses that produce the characteristic signs of allergic reactions.

The prescribed dose of Levocetirizine Teva is determined by the treating healthcare professional based on the patient’s age, condition, and renal function. Typically, adults receive a once‑daily oral dose, but exact dosing should follow the prescriber’s instructions.

Safety data for Levocetirizine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order Levocetirizine Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering higher affinity for the H1 receptor and often a lower incidence of sedation. Compared with first‑generation antihistamines, it provides effective symptom control with fewer central nervous system effects, making it a preferred option for many patients.

Levocetirizine Teva tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and avoid exposure to extreme temperatures or humidity.

Levocetirizine Teva is taken orally, usually as a whole tablet with or without food. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

Serious risks, although rare, include anaphylactic reactions, severe skin disorders such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, significant thrombocytopenia, and hepatic dysfunction. Patients should seek immediate medical attention if they experience signs of these conditions.

Levocetirizine Teva should be avoided in individuals with known hypersensitivity to levocetirizine, other piperazine antihistamines, or any of the excipients in the tablet. Caution is also advised for patients with severe renal impairment, pregnant or nursing women, and those taking interacting medications.